Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3509180010 | Sodium glucose cotransporter subtype 2 inhibitor (disposition) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3509181014 | Sodium glucose cotransporter subtype 2 inhibitor | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4058051000052115 | hämmare av natrium-glukossymportör, subtyp 2 | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sodium glucose cotransporter subtype 2 inhibitor (disposition) | Is a | Cellular transport inhibitor (disposition) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sodium glucose cotransporter subtype 2 inhibitor | Has disposition (attribute) | True | Sodium glucose cotransporter subtype 2 inhibitor (disposition) | Inferred relationship | Some | |
| Dapagliflozin (substance) | Has disposition (attribute) | True | Sodium glucose cotransporter subtype 2 inhibitor (disposition) | Inferred relationship | Some | |
| Dapagliflozin propanediol | Has disposition (attribute) | True | Sodium glucose cotransporter subtype 2 inhibitor (disposition) | Inferred relationship | Some | |
| Canagliflozin | Has disposition (attribute) | True | Sodium glucose cotransporter subtype 2 inhibitor (disposition) | Inferred relationship | Some | |
| Empagliflozin | Has disposition (attribute) | True | Sodium glucose cotransporter subtype 2 inhibitor (disposition) | Inferred relationship | Some | |
| Canagliflozin hemihydrate (substance) | Has disposition (attribute) | True | Sodium glucose cotransporter subtype 2 inhibitor (disposition) | Inferred relationship | Some | |
| Ertugliflozin | Has disposition (attribute) | True | Sodium glucose cotransporter subtype 2 inhibitor (disposition) | Inferred relationship | Some | |
| Dapagliflozin propanediol monohydrate (substance) | Has disposition (attribute) | True | Sodium glucose cotransporter subtype 2 inhibitor (disposition) | Inferred relationship | Some | |
| Ertugliflozin pidolate | Has disposition (attribute) | True | Sodium glucose cotransporter subtype 2 inhibitor (disposition) | Inferred relationship | Some | |
| Remogliflozin etabonate | Has disposition (attribute) | True | Sodium glucose cotransporter subtype 2 inhibitor (disposition) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR